Role of TGFβ in the anti-estrogen response/resistance of human breast cancer
- 1 October 1996
- journal article
- review article
- Published by Springer Nature in Journal of Mammary Gland Biology and Neoplasia
- Vol. 1 (4) , 381-389
- https://doi.org/10.1007/bf02017394
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Transforming Growth Factor βClinical Immunotherapeutics, 1995
- Absence of transforming growth factor-β responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1Journal of Cellular Biochemistry, 1994
- Alternative mechanisms of action of anti-oestrogensBreast Cancer Research and Treatment, 1994
- Desmoid tumours treated with triphenylethylenesEuropean Journal Of Cancer, 1992
- TGF-β: Regulation of extracellular matrixKidney International, 1992
- Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancerBritish Journal of Cancer, 1991
- Distribution and modulation of the cellular receptor for transforming growth factor-beta.The Journal of cell biology, 1987
- Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptorBiochemical and Biophysical Research Communications, 1986
- Autocrine and paracrine growth regulation of human breast cancerBreast Cancer Research and Treatment, 1986
- Autocrine growth factors and cancerNature, 1985